176 related articles for article (PubMed ID: 17194595)
1. Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists.
Chiba J; Iimura S; Yoneda Y; Watanabe T; Muro F; Tsubokawa M; Iigou Y; Satoh A; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2007 Feb; 15(4):1679-93. PubMed ID: 17194595
[TBL] [Abstract][Full Text] [Related]
2. Identification of 4-[1-[3-chloro-4-[N'-(5-fluoro-2-methylphenyl)ureido]phenylacetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]benzoic acid as a potent, orally active VLA-4 antagonist.
Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2008 Dec; 16(23):9991-10000. PubMed ID: 18952443
[TBL] [Abstract][Full Text] [Related]
3. A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid.
Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Bioorg Med Chem; 2009 Feb; 17(3):1232-43. PubMed ID: 19124247
[TBL] [Abstract][Full Text] [Related]
4. Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist.
Chiba J; Machinaga N; Takashi T; Ejima A; Takayama G; Yokoyama M; Nakayama A; Baldwin JJ; McDonald E; Moriarty KJ; Sarko CR; Saionz KW; Swanson R; Hussain Z; Wong A
Bioorg Med Chem Lett; 2005 Jan; 15(1):41-5. PubMed ID: 15582407
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists.
Chiba J; Takayama G; Takashi T; Yokoyama M; Nakayama A; Baldwin JJ; McDonald E; Moriarty KJ; Sarko CR; Saionz KW; Swanson R; Hussain Z; Wong A; Machinaga N
Bioorg Med Chem; 2006 Apr; 14(8):2725-46. PubMed ID: 16377201
[TBL] [Abstract][Full Text] [Related]
6. Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.
Muro F; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Matsumoto K; Satoh A; Takayama G; Taira T; Yokoyama M; Takashi T; Nakayama A; Machinaga N
J Med Chem; 2009 Dec; 52(24):7974-92. PubMed ID: 19891440
[TBL] [Abstract][Full Text] [Related]
7. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives.
Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y
Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I.
Imanishi M; Tomishima Y; Itou S; Hamashima H; Nakajima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
J Med Chem; 2008 Mar; 51(6):1925-44. PubMed ID: 18307290
[TBL] [Abstract][Full Text] [Related]
9. Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.
Witherington J; Blaney EL; Bordas V; Elliott RL; Gaiba A; Garton N; Green PM; Naylor A; Smith DG; Spalding DJ; Takle AK; Ward RW
Bioorg Med Chem Lett; 2006 Nov; 16(21):5538-41. PubMed ID: 16931004
[TBL] [Abstract][Full Text] [Related]
10. Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids.
Salem OI; Frotscher M; Scherer C; Neugebauer A; Biemel K; Streiber M; Maas R; Hartmann RW
J Med Chem; 2006 Jan; 49(2):748-59. PubMed ID: 16420060
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
Nakajima Y; Imanishi M; Itou S; Hamashima H; Tomishima Y; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Hattori K
Bioorg Med Chem Lett; 2008 Sep; 18(18):5037-40. PubMed ID: 18752946
[TBL] [Abstract][Full Text] [Related]
12. Influence of acid surrogates toward potency of VLA-4 antagonist.
Venkatraman S; Lim J; Cramer M; Gardner MF; James J; Alves K; Lingham RB; Mumford RA; Munoz B
Bioorg Med Chem Lett; 2005 Sep; 15(18):4053-6. PubMed ID: 16039122
[TBL] [Abstract][Full Text] [Related]
13. Imidazopyridines as VLA-4 integrin antagonists.
Phillips DJ; Davenport RJ; Demaude TA; Galleway FP; Jones MW; Knerr L; Perry BG; Ratcliffe AJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):4146-9. PubMed ID: 18539454
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffolds.
Stoermer D; Vitharana D; Hin N; Delahanty G; Duvall B; Ferraris DV; Grella BS; Hoover R; Rojas C; Shanholtz MK; Smith KP; Stathis M; Wu Y; Wozniak KM; Slusher BS; Tsukamoto T
J Med Chem; 2012 Jun; 55(12):5922-32. PubMed ID: 22642259
[TBL] [Abstract][Full Text] [Related]
15. 4-(Pyrrolidinyl)methoxybenzoic acid derivatives as a potent, orally active VLA-4 antagonist.
Chiba J; Iimura S; Yoneda Y; Sugimoto Y; Horiuchi T; Muro F; Ochiai Y; Ogasawara T; Tsubokawa M; Iigou Y; Takayama G; Taira T; Takata Y; Yokoyama M; Takashi T; Nakayama A; Machinaga N
Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1515-29. PubMed ID: 17077548
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
[TBL] [Abstract][Full Text] [Related]
17. Discovery of inhibitors of plasminogen activator inhibitor-1: structure-activity study of 5-nitro-2-phenoxybenzoic acid derivatives.
Pandya V; Jain M; Chakrabarti G; Soni H; Parmar B; Chaugule B; Patel J; Joshi J; Joshi N; Rath A; Raviya M; Shaikh M; Sairam KV; Patel H; Patel P
Bioorg Med Chem Lett; 2011 Oct; 21(19):5701-6. PubMed ID: 21880486
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a potent, orally bioavailable pyrimidine VLA-4 antagonist effective in a sheep asthma model.
Semko CM; Chen L; Dressen DB; Dreyer ML; Dunn W; Farouz FS; Freedman SB; Holsztynska EJ; Jefferies M; Konradi AW; Liao A; Lugar J; Mutter L; Pleiss MA; Quinn KP; Thompson T; Thorsett ED; Vandevert C; Xu YZ; Yednock TA
Bioorg Med Chem Lett; 2011 Mar; 21(6):1741-3. PubMed ID: 21316228
[TBL] [Abstract][Full Text] [Related]
19. Bioisosteric replacement of anilide with benzoxazole: potent and orally bioavailable antagonists of VLA-4.
Lin LS; Lanza TJ; Castonguay LA; Kamenecka T; McCauley E; Van Riper G; Egger LA; Mumford RA; Tong X; MacCoss M; Schmidt JA; Hagmann WK
Bioorg Med Chem Lett; 2004 May; 14(9):2331-4. PubMed ID: 15081035
[TBL] [Abstract][Full Text] [Related]
20. Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3',5'-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist.
Venkatraman S; Lebsack AD; Alves K; Gardner MF; James J; Lingham RB; Maniar S; Mumford RA; Si Q; Stock N; Treonze KM; Wang B; Zunic J; Munoz B
Bioorg Med Chem Lett; 2009 Oct; 19(19):5803-6. PubMed ID: 19713111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
